Skip to main content
Top
Published in: European Radiology 1/2017

01-01-2017 | Gastrointestinal

Magnetization transfer ratio for the assessment of perianal fistula activity in Crohn's disease

Authors: C. Pinson, M. Dolores, Y. Cruypeninck, E. Koning, J. N. Dacher, G. Savoye, C. Savoye-Collet

Published in: European Radiology | Issue 1/2017

Login to get access

Abstract

Objectives

Assessment of perianal fistulas is important to guide management of Crohn's disease (CD). Our objectives were to analyze the feasibility of magnetization transfer (MT) imaging to assess fistulas and to evaluate its contribution in assessing disease activity.

Methods

During 15 months, all patients referred for perianal fistulas in CD underwent 3T-MRI including diffusion, T2/T1-weighted gadolinium-enhanced sequences and MT sequences (one with an off-resonance saturation pulse of 800 and one with 1200 Hz). We collected Van Assche score, fistula activity signs by analyzing T2, diffusion and contrast enhancement. We calculated MT ratio (MTR) with a ROI in the largest fistula.

Results

Twenty-nine patients (mean 34.9 years, range 17-53) were included. Van Assche score was 11.7, range 4–21. In 22 patients, the fistula presented with a bright T2 and diffusion signal with contrast enhancement, and was characterized as active. Mean MTR was respectively 47.2 (range 12–68) and 34.3 (range 11–57) at 800 and 1200 Hz. MTR at 800 Hz was significantly lower in non-active (34, range 12–55) than in active fistulas (51, range 24–68) (p < 0.02).

Conclusions

MTR is feasible for the assessment of fistulas in CD and in the future could be used to help identify active and non-active fistulas.

Key Points

MTR is feasible for the assessment of perianal fistulas in CD.
• MT allows quantitative imaging of perianal fistula activity in CD.
MTR could be used to help identify active and non-active fistulas in CD.
Literature
1.
go back to reference Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 122:875–880CrossRefPubMed Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 122:875–880CrossRefPubMed
2.
go back to reference Ingle SB, Loftus EV Jr (2007) The natural history of perianal Crohn's disease. Dig Liver Dis 39:963–969CrossRefPubMed Ingle SB, Loftus EV Jr (2007) The natural history of perianal Crohn's disease. Dig Liver Dis 39:963–969CrossRefPubMed
4.
go back to reference Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB, American gastroenterological association clinical practice committee (2003) AGA technical review on perianal Crohn’s disease. Gastroenterology 125:1508–1530CrossRefPubMed Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB, American gastroenterological association clinical practice committee (2003) AGA technical review on perianal Crohn’s disease. Gastroenterology 125:1508–1530CrossRefPubMed
5.
go back to reference Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340:1398–1405CrossRefPubMed Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340:1398–1405CrossRefPubMed
6.
go back to reference Irvine EJ (1995) Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 20:27–32CrossRefPubMed Irvine EJ (1995) Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 20:27–32CrossRefPubMed
7.
go back to reference Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W (2003) Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 18:1113–1120CrossRefPubMed Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W (2003) Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 18:1113–1120CrossRefPubMed
8.
go back to reference Bell SJ, Halligan S, Windsor AC, Williams AB, Wiesel P, Kamm MA (2003) Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 17:387–393CrossRefPubMed Bell SJ, Halligan S, Windsor AC, Williams AB, Wiesel P, Kamm MA (2003) Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 17:387–393CrossRefPubMed
9.
go back to reference Van Assche G, Vanbeckevoort D, Bielen D et al (2003) Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 98:332–339CrossRefPubMed Van Assche G, Vanbeckevoort D, Bielen D et al (2003) Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 98:332–339CrossRefPubMed
10.
go back to reference Panes J, Bouhnik Y, Reinisch W et al (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohn's Colitis 7:556–585CrossRef Panes J, Bouhnik Y, Reinisch W et al (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohn's Colitis 7:556–585CrossRef
11.
go back to reference Savoye-Collet C, Savoye G, Koning E, Dacher JN, Lerebours E (2011) Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy. Inflamm Bowel Dis 17:1751–1758CrossRefPubMed Savoye-Collet C, Savoye G, Koning E, Dacher JN, Lerebours E (2011) Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy. Inflamm Bowel Dis 17:1751–1758CrossRefPubMed
12.
go back to reference Horsthuis K, Lavini C, Bipat S, Stokkers PC, Stoker J (2009) Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology 251:380–387CrossRefPubMed Horsthuis K, Lavini C, Bipat S, Stokkers PC, Stoker J (2009) Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology 251:380–387CrossRefPubMed
13.
go back to reference Ziech ML, Lavini C, Bipat S et al (2013) Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing Crohn disease: a pilot study. AJR Am J Roentgenol 200:W170–W177CrossRefPubMed Ziech ML, Lavini C, Bipat S et al (2013) Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing Crohn disease: a pilot study. AJR Am J Roentgenol 200:W170–W177CrossRefPubMed
14.
go back to reference Tozer P, Ng SC, Siddiqui MR et al (2012) Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas. Inflamm Bowel Dis 18:1825–1834CrossRefPubMed Tozer P, Ng SC, Siddiqui MR et al (2012) Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas. Inflamm Bowel Dis 18:1825–1834CrossRefPubMed
15.
go back to reference Savoye G, Savoye-Collet C (2010) How deep is remission in perianal Crohn's disease and do imaging modalities matter? Am J Gastroenterol 105:1445–1446CrossRefPubMed Savoye G, Savoye-Collet C (2010) How deep is remission in perianal Crohn's disease and do imaging modalities matter? Am J Gastroenterol 105:1445–1446CrossRefPubMed
16.
go back to reference Tissot O, Bodnar D, Henry L, Dubreuil A, Valette PJ (1996) Ano-perineal fistula in MRI. Contribution of T2 weighted sequences]. [Article in French. J Radiol 77:253–260PubMed Tissot O, Bodnar D, Henry L, Dubreuil A, Valette PJ (1996) Ano-perineal fistula in MRI. Contribution of T2 weighted sequences]. [Article in French. J Radiol 77:253–260PubMed
17.
go back to reference Szurowska E, Wypych J, Izycka-Swieszewska E (2007) Perianal fistulas in Crohn’s disease: MRI diagnosis and surgical planning: MRI in fistulazing perianal Crohn’s disease. Abdom Imaging 32:705–718CrossRefPubMed Szurowska E, Wypych J, Izycka-Swieszewska E (2007) Perianal fistulas in Crohn’s disease: MRI diagnosis and surgical planning: MRI in fistulazing perianal Crohn’s disease. Abdom Imaging 32:705–718CrossRefPubMed
19.
go back to reference Hori M, Oto A, Orrin S, Suzuki K, Baron RL (2009) Diffusion-weighted MRI: a new tool for the diagnosis of fistula in ano. J Magn Reson Imaging 30:1021–1026CrossRefPubMed Hori M, Oto A, Orrin S, Suzuki K, Baron RL (2009) Diffusion-weighted MRI: a new tool for the diagnosis of fistula in ano. J Magn Reson Imaging 30:1021–1026CrossRefPubMed
20.
go back to reference Dohan A, Eveno C, Oprea R et al (2014) Diffusion-weighted MR imaging for the diagnosis of abscess complicating fistula-in-ano: preliminary experience. Eur Radiol 24:2906–2915CrossRefPubMed Dohan A, Eveno C, Oprea R et al (2014) Diffusion-weighted MR imaging for the diagnosis of abscess complicating fistula-in-ano: preliminary experience. Eur Radiol 24:2906–2915CrossRefPubMed
21.
go back to reference Yoshizako T, Wada A, Takahara T et al (2012) Diffusion-weighted MRI for evaluating perianal fistula activity: feasibility study. Eur J Radiol 81:2049–2053CrossRefPubMed Yoshizako T, Wada A, Takahara T et al (2012) Diffusion-weighted MRI for evaluating perianal fistula activity: feasibility study. Eur J Radiol 81:2049–2053CrossRefPubMed
22.
go back to reference Adler J, Swanson SD, Schmiedlin-Ren P et al (2011) Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 259:127–135CrossRefPubMedPubMedCentral Adler J, Swanson SD, Schmiedlin-Ren P et al (2011) Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 259:127–135CrossRefPubMedPubMedCentral
23.
go back to reference Dillman JR, Swanson SD, Johnson LA et al (2014) Comparison of noncontrast MRI magnetization transfer and T2 -Weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn's disease animal model. J Magn Reson Imaging. doi:10.1002/jmri.24815 [Epub ahead of print] PubMed Dillman JR, Swanson SD, Johnson LA et al (2014) Comparison of noncontrast MRI magnetization transfer and T2 -Weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn's disease animal model. J Magn Reson Imaging. doi:10.​1002/​jmri.​24815 [Epub ahead of print] PubMed
24.
go back to reference Pazahr S, Blume I, Frei P et al (2013) Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn’s disease: initial experience. MAGMA 26:291–301CrossRefPubMed Pazahr S, Blume I, Frei P et al (2013) Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn’s disease: initial experience. MAGMA 26:291–301CrossRefPubMed
25.
go back to reference Adler J, Rahal K, Swanson SD et al (2013) Anti-tumor necrosis factor α prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn’s disease. Inflamm Bowel Dis 19:683–690CrossRefPubMed Adler J, Rahal K, Swanson SD et al (2013) Anti-tumor necrosis factor α prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn’s disease. Inflamm Bowel Dis 19:683–690CrossRefPubMed
26.
go back to reference Henkelman RM, Stanisz GJ, Graham SJ (2001) Magnetization transfer in MRI: a review. NMR Biomed 14:57–64CrossRefPubMed Henkelman RM, Stanisz GJ, Graham SJ (2001) Magnetization transfer in MRI: a review. NMR Biomed 14:57–64CrossRefPubMed
27.
go back to reference Wolff SD, Balaban RS (1994) Magnetization transfer imaging: practical aspects and clinical applications. Radiology 192:593–599CrossRefPubMed Wolff SD, Balaban RS (1994) Magnetization transfer imaging: practical aspects and clinical applications. Radiology 192:593–599CrossRefPubMed
28.
29.
go back to reference Kumar V, Jagannathan NR, Kumar R et al (2008) Evaluation of the role of magnetization transfer imaging in prostate: a preliminary study. Magn Reson Imaging 26:644–649CrossRefPubMed Kumar V, Jagannathan NR, Kumar R et al (2008) Evaluation of the role of magnetization transfer imaging in prostate: a preliminary study. Magn Reson Imaging 26:644–649CrossRefPubMed
30.
go back to reference Ng SC, Plamondon S, Gupta A et al (2009) Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas. Am J Gastroenterol 104:2973–2986CrossRefPubMed Ng SC, Plamondon S, Gupta A et al (2009) Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas. Am J Gastroenterol 104:2973–2986CrossRefPubMed
Metadata
Title
Magnetization transfer ratio for the assessment of perianal fistula activity in Crohn's disease
Authors
C. Pinson
M. Dolores
Y. Cruypeninck
E. Koning
J. N. Dacher
G. Savoye
C. Savoye-Collet
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 1/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4350-2

Other articles of this Issue 1/2017

European Radiology 1/2017 Go to the issue